MENU
PLUR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Pluri (PLUR) Ownership - Who owns Pluri?

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
MATAM Advanced Technology Park
Phone
+972 747108600
Employees
142
Web
https://www.pluri-biotech.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
22.6M
P/E Ratio
N/A
Total Cash
9.32M
Projected Growth
N/A
Total Debt
33.63M
Revenue
1.08M
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash/Share
0.86
Total Debt/Equity
N/A
Revenue/Share
0.12 USD as % of share price
View a ticker or compare two or three
PLUR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of stem cell production technology

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
MATAM Advanced Technology Park
Phone
+972 747108600
Employees
142
Web
https://www.pluri-biotech.com